IQVIA Pharma Deals Review
ISSN 1756-7874. The business journal providing incisive analysis and expert opinion on the major deals.
Pharma Deals Review Latest Articles
-
Amphista Enters Protein Degradation Collaborations with Bristol-Myers Squibb and Merck
-
Pfizer Buys Biohaven for US$11.6 B
-
Jazz Licenses Sumitomo’s Narcolepsy Drug for US$50 M Upfront
-
Caladrius and Cend Merge to Become Lisata Therapeutics
-
Regeneron Bolsters I-O Portfolio with US$250 M Checkmate Acquisition
You can click on any of the bars to open a new page with the corresponding deals.